Handson Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 11-12-2024
- Paid Up Capital ₹ 0.90 M
as on 11-12-2024
- Company Age 38 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 54.48%
(FY 2022)
- Profit -16.86%
(FY 2022)
- Ebitda -39.10%
(FY 2022)
- Net Worth -78.63%
(FY 2022)
- Total Assets 4.60%
(FY 2022)
About Handson Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Meera Dhawan, Gayatri Dhawan, Shyam Chauhan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232UP1986PTC008361
- Company No.
008361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Saharanpur, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Handson Pharmaceuticals Private Limited offer?
Handson Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Antipyretic Medication, Digestive System Drugs & Medicines, Antacid Drugs, Nutraceuticals & Dietary Supplements, Mineral Supplement, Fertilizers and Soil Additives.
Who are the key members and board of directors at Handson Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meera Dhawan  | Director | 04-May-2007 | Current |
| Gayatri Dhawan | Director | 29-Apr-2011 | Current |
| Shyam Chauhan | Additional Director | 21-Sep-2020 | Current |
| Raghav Dhawan | Director | 28-Apr-2018 | Current |
Financial Performance of Handson Pharmaceuticals.
Handson Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 54.48% increase. The company also saw a substantial fall in profitability, with a 16.86% decrease in profit. The company's net worth observed a substantial decline by a decrease of 78.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Handson Pharmaceuticals?
Unlock access to Handson Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Handson Pharmaceuticals?
Unlock and access historical data on people associated with Handson Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Handson Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Handson Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
